Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.57 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | PDE10A | Q9Y233 | 5/20 | 0.55 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.55 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.55 |
| ▸ | APP | P05067 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.50 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22622262 | 0.91 | LMNA (0.62) | PPARAFFAR4FFAR1APPLMNA | |
| SCHEMBL3693650 | 0.89 | LMNA (0.60) | PPARAFFAR4FFAR1APPLMNA | |
| SCHEMBL347209 | 0.86 | FFAR4 (0.61) | FFAR4FFAR1PLA2G4A | |
| SCHEMBL3690496 | 0.85 | CALM1 (0.60) | PPARAFFAR4FFAR1APPPLA2G4A | |
| SCHEMBL8133000 | 0.85 | KDM4E (0.57) | PPARAFFAR4FFAR1APPLMNA | |
| Hydrochloric Acid SCHEMBL3225386 | 0.85 | FFAR4 (0.59) | FFAR4FFAR1PLA2G4A | |
| SCHEMBL9178046 | 0.84 | FFAR4 (0.55) | PPARAFFAR4FFAR1APPFFAR2 | |
| SCHEMBL5685578 | 0.84 | CYP4F2 (0.54) | PDE10APDE3BPDE3AAPPLMNA | |
| SCHEMBL31322145 | 0.83 | ALOX5 (0.62) | PPARAFFAR4FFAR1APPLMNA | |
| SCHEMBL3974023 | 0.82 | FFAR4 (0.51) | PPARAFFAR4FFAR1APPLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060122064-A1 | Amides and method for plant diseases control with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1640360-A1 | AMIDES AND METHOD FOR PLANT DISEASE CONTROL WITH THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122064-A1 | Amides and method for plant diseases control with the same | ARG1, ARGLU1, ARG2 | PPARA 1528/4885FFAR4 3414/4885FFAR1 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.